Charles Oehrlein, DPM
Podiatrist · Hoover, ALNPI 1326031451
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.9% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $176 and has fallen 56.4% since, to $77 in 2025. That places this record below the midpoint for podiatrist clinicians in AL, where the typical reported total is $1,120.
Across 26 payments — averaging $28.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$158
- Kerecis Limited$133
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$115
- Organogenesis Inc.$101
- Amgen$44
- Averitas Pharma Inc.$36
- plus $155 from 7 others
What the payments were for
- Speaking & faculty fees$608%
- Food & beverage$68292%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 2 | $158 |
| Kerecis Limited | 3 | $133 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $115 |
| Organogenesis Inc. | 3 | $101 |
| Amgen | 2 | $44 |
| Averitas Pharma Inc. | 2 | $36 |
| Zyla Life Sciences, Inc. | 2 | $33 |
| Mimedx Group, Inc. | 2 | $33 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Saluda Medical Americas, Inc. | 1 | $19 |
| Alfasigma USA, Inc. | 1 | $18 |
| Boston Scientific | 1 | $17 |
| Hartmann USA, Inc. | 1 | $15 |
How this compares
$742 in reported general payments places this provider in the 40th percentile of 59 podiatrist providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 54 | $8,846 |
| Halobetasol Propionate | 11 | $2,951 |
| Celecoxib | 126 | $1,594 |
| Fluticasone Propionate | 13 | $1,188 |
| Terbinafine Hcl | 70 | $1,165 |
| Methylprednisolone | 43 | $360 |
| Ammonium Lactate | 12 | $354 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $99 |
| Meloxicam | 11 | $48 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Hoover
- Benjamin BrannickHoover$3K
- Michael HamesFlorence$100K
- James MorganMobile$21K
- John RobersonBirmingham$10K
- Kyle MaukBirmingham$10K
- Johnnie AlstonMontgomery$9K
- Heidi ChristieMontgomery$7K
- Brent HaverstockBirmingham$7K
- David LindeBirmingham$6K
- Robert OcampoCullman$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.